Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Aurobindo Pharma got final approvals from the US FDA of azithromycin for injection USP, 500mg /vial and entacapone tablets. Azithromycin for injection USP, 500mg/vial is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zithromax (azithromycin for injection) 500mg/vial of Pfizer, Inc. Azithromycin for injection, USP is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions such as community-acquired pneumonia and pelvic inflammatory disease.

  • Australian researchers have developed a breakthrough vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting over 450,000 people in the country. Lead researcher Ranjeny Thomas from the University of Queensland's Diamantina Institute said results from the phase one clinical trial demonstrate the new treatment is safe and effective in supressing the immune response.

  • The research conducted by Dundee University, Scotland explained that the newly developed drug could work well against parasites resistant to current treatments of the mosquito-borne disease. Researchers  discovered a new compound, DDD107498 to treat malaria in a single dose, protects people from the disease and prevent the transmission of infection. The research is printed  in the journal 'Nature'.

  • Shri B P Sharma, Secretary Health, Ministry of Health & Family Welfare and Chairman, Indian Pharmacopoeia Commission, Government of India launched an Android Mobile Applications for Adverse Drug Reactions (ADRs) reporting facility to the stakeholders of Pharmacovigilance Programme of India (PvPI). The mobile application for ADR reporting was specifically designed to facilitate the needs of the IPC, to ensure hassle free ADR reporting for the stakeholders. The mobile application is expected to provide a platform for the private healthcare professionals to report ADRs to safeguard and enhance public health by ensuring the safety, efficacy and quality of drugs.

  • An experimental drug from the US-based Eli Lilly and Company discovered to protect Alzheimer's-inflicted mice from memory deterioration, despite a high-glycemic-index (GI) diet meant to boost blood sugar levels. The experimental drug mimics the hunger-signaling hormone ghrelin.

  • Upto 3% of the global population suffering from Ankylosing spondylitis and two other debilitating conditions. Ankylosing spondylitis, a painful form of arthritis is an incurable immune disease affecting the spine, joints and tendons, and can be difficult to diagnose.

  • A new research suggests that a simple blood or urine test could soon identify men with an elevated, genetically-inherited risk for the disease. The study is available online and will be published in an upcoming issue of the journal Cancer Discovery.

  • The Andhra Pradesh government has launched a new software application ‘e-Aushadini’ to manage stocks of various drugs in government hospitals. The main aim of 'e-Aushadini' is to ascertain the needs of various district drug warehouses such that all the required materials/drugs are constantly available to be supplied to the user district drug warehouses without delay.

  • (NewsVoir); Aggressively moving towards its expansion plans, 1mg.com - India’s leading m-health platform that has also been operating the largest e-Pharmacy marketplace in the country, announced today that it has decided to expand the scope of its platform and is entering the alternate medicine space (AYUSH categories) through the acquisition of www. Homeobuy.com. Homeobuy is a web platform for homeopathy medicines. With this acquisition, 1mg will re-brand the website to www. 1mgAyush.com and make Homeopathic & Ayurvedic medicines available to customers in New Delhi.

    [adsense:336x280:8701650588]

Subscribe to Pharma News